Malignant tumors of liver and intrahepatic bile duct
Conditions
Interventions
TCM whole course management cohort and TCM supplementary treatment cohort:NA
Sponsors
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1.Patients who visited the tumor Clinic of Traditional Chinese Medicine in the First Affiliated Hospital of Guangzhou University of Chinese Medicine from January 1, 2020 to December 31, 2022; 2. Between the ages of 18 and 85; 3. Suitable for clinical or pathological diagnosis of primary liver cancer; 4. Have received at least one comprehensive treatment of Chinese and Western medicine (TCM treatment includes TCM decoction and proprietary Chinese medicine, Western treatment includes systemic/local anti-tumor treatment and supportive treatment).
Exclusion criteria
Exclusion criteria: 1. Barcelona stage of liver cancer (BCLC stage) is D; 2. Combined with serious or uncontrollable systemic diseases, such as serious mental and neurological diseases, dementia, epilepsy, unstable or uncompensable respiratory, cardiovascular and cerebrovascular diseases, kidney system diseases; 3. Have been diagnosed with another malignant tumor within the last 5 years (excluding cured malignant tumors); 4. Patients with unclear diagnosis and treatment data; 5. Pregnant or lactating women; 6. The medical records were clearly recorded as patients with poor compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to disease recurrence;Weight changes of three TCM treatments;quality of life; | — |
Countries
China
Contacts
Public ContactZhou Daihan
12 Airport Road, Baiyun District, Guangzhou, Guangdong, China
Outcome results
None listed